ATA602576A - Verfahren zur herstellung von neuen tert- -butylaminopropoxy-indolen und ihren saeure- additionssalzen - Google Patents

Verfahren zur herstellung von neuen tert- -butylaminopropoxy-indolen und ihren saeure- additionssalzen

Info

Publication number
ATA602576A
ATA602576A AT602576A AT602576A ATA602576A AT A602576 A ATA602576 A AT A602576A AT 602576 A AT602576 A AT 602576A AT 602576 A AT602576 A AT 602576A AT A602576 A ATA602576 A AT A602576A
Authority
AT
Austria
Prior art keywords
butylaminopropoxy
indols
acid addition
addition salts
producing new
Prior art date
Application number
AT602576A
Other languages
English (en)
Other versions
AT363070B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA602576A publication Critical patent/ATA602576A/de
Application granted granted Critical
Publication of AT363070B publication Critical patent/AT363070B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AT0602576A 1975-08-15 1976-08-13 Verfahren zur herstellung von neuen tert-butylaminopropoxy-indolen und ihren saeureadditionssalzen AT363070B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1071475 1975-08-15

Publications (2)

Publication Number Publication Date
ATA602576A true ATA602576A (de) 1980-12-15
AT363070B AT363070B (de) 1981-07-10

Family

ID=4366041

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0602576A AT363070B (de) 1975-08-15 1976-08-13 Verfahren zur herstellung von neuen tert-butylaminopropoxy-indolen und ihren saeureadditionssalzen

Country Status (28)

Country Link
US (1) US4434176A (de)
JP (2) JPS5223073A (de)
AT (1) AT363070B (de)
AU (1) AU505719B2 (de)
BE (1) BE845197R (de)
CA (1) CA1080720A (de)
CY (1) CY1225A (de)
DE (1) DE2635209C2 (de)
DK (1) DK152120C (de)
ES (1) ES450681A1 (de)
FI (1) FI63751C (de)
FR (1) FR2320743A2 (de)
GB (2) GB1575510A (de)
HK (1) HK35884A (de)
IE (1) IE43797B1 (de)
IL (2) IL50263A (de)
KE (1) KE3404A (de)
MY (1) MY8500135A (de)
NL (2) NL176362C (de)
NO (1) NO762735L (de)
NZ (1) NZ181764A (de)
PH (1) PH13356A (de)
PT (1) PT65477B (de)
SE (1) SE414633B (de)
SG (1) SG84883G (de)
SU (1) SU649313A3 (de)
YU (1) YU198876A (de)
ZA (1) ZA764883B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
JPS58106499A (ja) * 1981-12-19 1983-06-24 株式会社東芝 燃料交換装置のクランプ解除機構
NL8600137A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten.
US5174210A (en) * 1990-04-27 1992-12-29 Heidelberger Druckmaschinen Aktiengesellschaft Preparation of the inking unit of a printing press for a change of printing job
EP0750608A1 (de) * 1994-01-28 1997-01-02 Cal International Limited Pharmazeutisches produkt, welches ein salicylat eines veresterbaren beta-blockers enthält
GEP20084406B (en) * 2003-05-30 2008-06-25 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
AU2007274724B2 (en) * 2006-07-14 2012-07-26 Ranbaxy Laboratories Limited Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751429A (en) * 1970-03-24 1973-08-07 Sandoz Ltd 4-(3-amino-2-substituted propoxy)indole derivatives
CH532040A (de) * 1970-03-24 1972-12-31 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
SE375771B (de) * 1970-09-30 1975-04-28 Sandoz Ag
CH545784A (en) * 1971-01-07 1974-02-15 Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles
CH545783A (en) * 1971-01-07 1974-02-15 Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides

Also Published As

Publication number Publication date
JPS5649318A (en) 1981-05-02
CA1080720A (en) 1980-07-01
NL7608902A (nl) 1977-02-17
HK35884A (en) 1984-05-04
FI63751B (fi) 1983-04-29
DE2635209A1 (de) 1977-02-24
FR2320743A2 (fr) 1977-03-11
YU198876A (en) 1982-05-31
SU649313A3 (ru) 1979-02-25
FI63751C (fi) 1983-08-10
DK357576A (da) 1977-02-16
SE414633B (sv) 1980-08-11
IE43797B1 (en) 1981-06-03
BE845197R (fr) 1977-02-14
ZA764883B (en) 1978-03-29
NZ181764A (en) 1978-06-20
PT65477B (fr) 1978-05-10
IL50263A (en) 1980-06-30
FR2320743B2 (de) 1978-11-17
CY1225A (en) 1984-04-06
PH13356A (en) 1980-03-20
PT65477A (fr) 1976-09-01
NL930134I2 (nl) 1996-11-01
DK152120C (da) 1988-06-20
FI762258A (de) 1977-02-16
SG84883G (en) 1985-01-11
AU505719B2 (en) 1979-11-29
IL50263A0 (en) 1976-10-31
US4434176A (en) 1984-02-28
IL58163A0 (en) 1979-12-30
JPS5223073A (en) 1977-02-21
IE43797L (en) 1977-02-15
NL176362C (nl) 1985-04-01
KE3404A (en) 1985-02-01
DE2635209C2 (de) 1983-01-27
JPS568834B2 (de) 1981-02-25
NO762735L (de) 1977-02-16
AT363070B (de) 1981-07-10
DK152120B (da) 1988-02-01
GB1575510A (en) 1980-09-24
NL176362B (nl) 1984-11-01
MY8500135A (en) 1985-12-31
NL930134I1 (nl) 1993-11-01
AU1684176A (en) 1978-02-16
GB1575509A (en) 1980-09-24
SE7608865L (sv) 1977-02-16
ES450681A1 (es) 1977-11-16

Similar Documents

Publication Publication Date Title
AT344683B (de) Verfahren zur herstellung von neuen substituierten 3-phenoxy-2-hydroxy-1-aminopropanen und deren saeureadditionssalzen
AT340895B (de) Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
AT352127B (de) Verfahren zur herstellung von neuen 1- substituierten-4-benzylpiperidinen und ihren saeureadditionssalzen
AT361478B (de) Verfahren zur herstellung von neuen 2-alkylen- aminodihydropyridinen und ihren saeureadditions- salzen
AT345833B (de) Verfahren zur herstellung von neuen benzimidazolinon-derivaten und ihren saeure- additionssalzen
AT360533B (de) Verfahren zur herstellung von neuen trans- -hexahydropyrido-indolen und ihren saeure- additionssalzen
AT358035B (de) Verfahren zur herstellung von neuen indolizin- derivaten und von ihren saeureadditionssalzen
ATA612476A (de) Verfahren zur herstellung von neuen phenoxyal- kylcarbonsaeurederivaten und ihren salzen
ATA602576A (de) Verfahren zur herstellung von neuen tert- -butylaminopropoxy-indolen und ihren saeure- additionssalzen
ATA702976A (de) Verfahren zur herstellung von neuen n-aryl-n- (4-piperidinyl)-arylacetamiden und ihren salzen
AT346303B (de) Verfahren zur herstellung von neuen 7- aminobenzocycloheptenen und deren saeure- additionssalzen
AT356110B (de) Verfahren zur herstellung von neuen benzyliso- chinolinderivaten und ihren saeureadditions- salzen
ATA307175A (de) Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen
AT342034B (de) Verfahren zur herstellung von neuen 4,4-diphenyl-2-hydroxybutylaminen und ihren salzen
AT340896B (de) Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen
ATA606175A (de) Verfahren zur herstellung von neuen prostansaeurederivaten und von ihren salzen
AT340897B (de) Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT358046B (de) Verfahren zur herstellung von neuen trans-5a- -aryl-decahydrobenzazepinen und ihren saeure- additionssalzen
AT357535B (de) Verfahren zur herstellung von neuen 4-amino- transdecahydrochinolinderivaten und ihren saeureadditionssalzen
AT358027B (de) Verfahren zur herstellung von neuen indol- derivaten und ihren salzen
AT355569B (de) Verfahren zur herstellung von neuen, substi- tuierten pyridoindolen und ihren salzen
AT342021B (de) Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
AT340894B (de) Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen
AT345293B (de) Verfahren zur herstellung von neuen 1-alkenyl-3a-m-substituiertes-phenyl-decahydroisochinolinen und ihren saeureaddtionssalzen
ATA162476A (de) Verfahren zur herstellung von neuen phenoxy- phenylbuttersaeure-derivaten sowie von ihren salzen

Legal Events

Date Code Title Description
SZA Application filed for a certificate of protection

Free format text: SZ146/94, 941230

EFA Change in the company name
EZF Grant of a certificate of protection

Free format text: SZ 146/94, 941230, EXPIRES:20031215

SZA Application filed for a certificate of protection

Free format text: SZ 146/94, 941230

ELA Expired due to lapse of time